157 related articles for article (PubMed ID: 8039452)
1. [The clinical significance of the ajmaline test in the noninvasive diagnosis of the Wolff-Parkinson-White syndrome].
Neuzner J; Pitschner HF; Jakob H; Schlepper M
Dtsch Med Wochenschr; 1994 Jul; 119(28-29):985-9. PubMed ID: 8039452
[TBL] [Abstract][Full Text] [Related]
2. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.
Maia IG; Cruz Filho FE; Fagundes ML; Boghossian SH; Vanheusden L; Sa RM; Alves PA
J Am Coll Cardiol; 1995 Nov; 26(5):1310-4. PubMed ID: 7594048
[TBL] [Abstract][Full Text] [Related]
3. [Ventricular pre-excitation: electrophysiopathology, criteria for interpretation and clinical diagnosis. References for geriatrics].
Tamburrini LR; Fontanelli A; Primossi G
Minerva Cardioangiol; 2001 Feb; 49(1):47-73. PubMed ID: 11279385
[TBL] [Abstract][Full Text] [Related]
4. [Wolff-Parkinson-White syndrome. Value of transesophageal atrial stimulation coupled with exercise test for the study of anterograde conduction in the accessory pathway].
Cebron JP; Le Marec H; Victor J; Chevallier JC; Borgat C; Godin JF
Arch Mal Coeur Vaiss; 1989 Feb; 82(2):159-66. PubMed ID: 2500076
[TBL] [Abstract][Full Text] [Related]
5. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
Duckeck W; Kuck KH
Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
[TBL] [Abstract][Full Text] [Related]
6. Increased P wave dispersion after the radiofrequency catheter ablation in overt pre-excitation patients: the role of atrial vulnerability.
Soylu M; Demir AD; Ozdemir O; Soylu O; Topaloğlu S; Korkmaz S; Saşmaz A
Int J Cardiol; 2004 Jun; 95(2-3):167-70. PubMed ID: 15193815
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiological effects of chloroacetyl ajmaline in Wolff-Parkinson-White syndrome].
Touboul P; Gressard A; Atallah G; Chatelain MT; Delahaye JP
Arch Mal Coeur Vaiss; 1978 Jul; 71(7):808-15. PubMed ID: 102281
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and electrophysiological study of asymptomatic Wolff-Parkinson-White syndrome].
Kibos A; Deharo JC; Adoubi A; Assouan X; Djianeb P
Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):237-40. PubMed ID: 17572371
[TBL] [Abstract][Full Text] [Related]
9. [Wolff-Parkinson-White syndrome. Value of intravenous flecainide for detecting Kent's pathways with short refractory period].
Talard P; Cointe R; Bru P; Moyal C; Lacombe P; Bremondy M; Levy S; Gerard R
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):489-92. PubMed ID: 2111669
[TBL] [Abstract][Full Text] [Related]
10. [Surgical atrioventricular disconnection in Wolff-Parkinson-White syndrome].
Pavie A; Mesnildrey P; Gandjbakhch I; Cabrol C; Fontaine G; Franck R; Grosgogeat Y; Slama R
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):606-15. PubMed ID: 6431924
[TBL] [Abstract][Full Text] [Related]
11. WPW and preexcitation syndromes.
Sethi KK; Dhall A; Chadha DS; Garg S; Malani SK; Mathew OP
J Assoc Physicians India; 2007 Apr; 55 Suppl():10-5. PubMed ID: 18368860
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological studies in patients with the Wolf-Parkinson-White syndrome.
Farré J; Ross DL; Wiener I; Bär FW; Vanagt E; Wellens HJ
Herz; 1979 Feb; 4(1):38-46. PubMed ID: 437670
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
Centurión OA; Shimizu A; Isomoto S; Konoe A
Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
[TBL] [Abstract][Full Text] [Related]
14. The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children.
Santinelli V; Radinovic A; Manguso F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Ciconte G; Sacchi S; Sala S; Pappone C
J Am Coll Cardiol; 2009 Jan; 53(3):275-80. PubMed ID: 19147045
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic characteristics and radiofrequency catheter ablation in children with Wolff-Parkinson-White syndrome.
Lee PC; Hwang B; Chen YJ; Tai CT; Chen SA; Chiang CE
Pacing Clin Electrophysiol; 2006 May; 29(5):490-5. PubMed ID: 16689844
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous flecainide in Wolff-Parkinson-White syndrome: a test for evaluation of the refractory period of the anomalous pathway. Comparison with ajmaline].
Klersy C; Marangoni E; Salerno JA; Guasti L; Chimienti M; Morellini MC; li Bergolis M; Moizi M; Tronconi L; Bobba P
Cardiologia; 1988 May; 33(5):531-5. PubMed ID: 3139291
[No Abstract] [Full Text] [Related]
17. Transcatheter ablation of the accessory pathway in 2 patients with life-threatening tachyarrhythmias.
Yang Y; Lin Z; Greco C; Ciccaglioni A; Sinatra R; Nigri A; Critelli G
Cardiologia; 1992 Apr; 37(4):291-6. PubMed ID: 1521254
[TBL] [Abstract][Full Text] [Related]
18. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
Liu S; Yuan S; Hertervig E; Kongstad O; Olsson SB
J Electrocardiol; 2001 Oct; 34(4):295-301. PubMed ID: 11590556
[TBL] [Abstract][Full Text] [Related]
19. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways].
Blanc JJ; Boschat J; Ollivier JP; Penther P
Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1097-102. PubMed ID: 3929739
[TBL] [Abstract][Full Text] [Related]
20. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
Dolla E; Levy S; Cointe R; Moyal C; Bru P; Rossi P; Gérard R
Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
